Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novavax Inc (NVAX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novavax Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1000694.
Total stock buying since 2014: $1,666,730.
Total stock sales since 2014: $211,819,919.
Total stock option exercises since 2014: $30,930,359.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 430,010 | $0 |
| 2024 | 0 | $0 | 76,216 | $1,069,544 | 303,115 | $364,087 |
| 2023 | 6,000 | $43,043 | 0 | $0 | 73,444 | $288,106 |
| 2022 | 0 | $0 | 17,500 | $1,631,537 | 31,357 | $95,399 |
| 2021 | 700 | $97,747 | 544,175 | $109,177,089 | 604,304 | $18,306,717 |
| 2020 | 2,750 | $78,070 | 431,120 | $50,835,351 | 510,022 | $10,931,487 |
| 2019 | 100,168 | $63,017 | 22,770 | $132,163 | 17,684 | $0 |
| 2018 | 195,791 | $302,054 | 0 | $0 | 0 | $0 |
| 2017 | 427,051 | $413,971 | 275,000 | $323,800 | 0 | $0 |
| 2016 | 291,195 | $521,477 | 474,778 | $2,474,002 | 400,000 | $511,999 |
| 2015 | 57,698 | $147,351 | 5,209,489 | $46,176,433 | 216,886 | $391,164 |
| 2014 | 0 | $0 | 0 | $0 | 45,000 | $41,400 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-14 | Trizzino John (EVP, CCO and CBO) | Option Ex | 7,499 | 19.08 | 143,080 |
| 2021-09-13 | Trizzino John (EVP, CCO and CBO) | Sale | 7,499 | 237.64 | 1,782,047 |
| 2021-09-13 | Trizzino John (EVP, CCO and CBO) | Option Ex | 7,499 | 19.08 | 143,080 |
| 2021-09-01 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 5,000 | 245.85 | 1,229,255 |
| 2021-09-01 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 5,000 | 19.08 | 95,399 |
| 2021-08-31 | Glenn Gregory M (President, R&D) | Sale | 1,386 | 239.87 | 332,463 |
| 2021-08-26 | Glenn Gregory M (President, R&D) | Sale | 4,167 | 234.56 | 977,407 |
| 2021-08-26 | Glenn Gregory M (President, R&D) | Option Ex | 6,921 | 5.95 | 41,179 |
| 2021-08-24 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,000 | .00 | 0 |
| 2021-08-16 | Glenn Gregory M (President, R&D) | Sale | 1,866 | 235.51 | 439,461 |
| 2021-08-16 | Glenn Gregory M (President, R&D) | Option Ex | 1,866 | 36.80 | 68,668 |
| 2021-07-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 2,896 | 198.88 | 575,947 |
| 2021-07-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,896 | 26.52 | 76,793 |
| 2021-07-20 | Glenn Gregory M (President, R&D) | Sale | 2,409 | 214.67 | 517,137 |
| 2021-07-15 | Glenn Gregory M (President, R&D) | Sale | 5,654 | 180.95 | 1,023,079 |
| 2021-07-15 | Glenn Gregory M (President, R&D) | Option Ex | 10,477 | 22.50 | 235,732 |
| 2021-07-02 | Erck Stanley C (President and CEO) | Sale | 52,559 | 216.10 | 11,358,105 |
| 2021-07-02 | Erck Stanley C (President and CEO) | Option Ex | 52,559 | 78.80 | 4,141,649 |
| 2021-07-01 | Erck Stanley C (President and CEO) | Sale | 52,620 | 212.54 | 11,183,802 |
| 2021-07-01 | Erck Stanley C (President and CEO) | Option Ex | 52,620 | 61.07 | 3,213,345 |
| 2021-07-01 | Young James F (Director) | Option Ex | 10,000 | .00 | 0 |
| 2021-06-30 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 2,896 | 213.04 | 616,958 |
| 2021-06-30 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,896 | 26.52 | 76,793 |
| 2021-06-25 | King Rachel K. (Director) | Option Ex | 6,900 | .00 | 0 |
| 2021-06-25 | Trizzino John (EVP, CCO, CBO & Interim CFO) | Option Ex | 834 | .00 | 0 |
| 2021-06-25 | Young James F (Director) | Option Ex | 7,590 | .00 | 0 |
| 2021-06-25 | Mcmanus Michael A Jr (Director) | Option Ex | 6,900 | .00 | 0 |
| 2021-06-25 | Douglas Richard (Director) | Option Ex | 3,450 | .00 | 0 |
| 2021-06-17 | Glenn Gregory M (President, R&D) | Sale | 2,411 | 183.28 | 441,888 |
| 2021-06-15 | Glenn Gregory M (President, R&D) | Sale | 5,716 | 191.88 | 1,096,786 |
| 2021-06-15 | Glenn Gregory M (President, R&D) | Option Ex | 10,535 | 22.50 | 237,037 |
| 2021-06-01 | Evans Gary C (Director) | Sale | 625 | 146.50 | 91,562 |
| 2021-05-19 | King Rachel K. (Director) | Buy | 700 | 139.64 | 97,747 |
| 2021-05-07 | Trizzino John (EVP, CCO, CBO & Interim CFO) | Sale | 190 | 176.62 | 33,558 |
| 2021-05-05 | Trizzino John (EVP, CCO, CBO & Interim CFO) | Sale | 3,022 | 181.10 | 547,272 |
| 2021-05-05 | Trizzino John (EVP, CCO, CBO & Interim CFO) | Option Ex | 3,406 | 21.38 | 72,803 |
| 2021-04-30 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 2,895 | 242.18 | 701,105 |
| 2021-04-30 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,895 | 26.52 | 76,766 |
| 2021-04-19 | Glenn Gregory M (President, R&D) | Sale | 2,417 | 218.50 | 528,124 |
| 2021-04-15 | Glenn Gregory M (President, R&D) | Sale | 5,712 | 201.80 | 1,152,687 |
| 2021-04-15 | Glenn Gregory M (President, R&D) | Option Ex | 10,531 | 61.73 | 650,057 |
| 2021-04-07 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 191 | 178.03 | 34,003 |
| 2021-04-05 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 3,021 | 190.10 | 574,292 |
| 2021-04-05 | Trizzino John (EVP, Chief Commercial Officer) | Option Ex | 3,404 | 64.21 | 218,570 |
| 2021-03-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 2,894 | 188.16 | 544,537 |
| 2021-03-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,894 | 26.52 | 76,740 |
| 2021-03-19 | Mcmanus Michael A Jr (Director) | Sale | 4,000 | 220.99 | 883,940 |
| 2021-03-17 | Glenn Gregory M (President, R&D) | Sale | 2,423 | 218.26 | 528,853 |
| 2021-03-15 | Glenn Gregory M (President, R&D) | Sale | 5,712 | 199.09 | 1,137,179 |
| 2021-03-15 | Glenn Gregory M (President, R&D) | Option Ex | 10,531 | 64.80 | 682,429 |
| 2021-03-15 | Evans Gary C (Director) | Sale | 24,500 | 211.00 | 5,169,500 |
| 2021-03-15 | Evans Gary C (Director) | Option Ex | 24,500 | 49.93 | 1,223,236 |
| 2021-03-09 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 190 | 168.09 | 31,937 |
| 2021-03-05 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 3,021 | 163.03 | 492,525 |
| 2021-03-05 | Trizzino John (EVP, Chief Commercial Officer) | Option Ex | 3,404 | 21.38 | 72,760 |
| 2021-02-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 2,895 | 225.72 | 653,444 |
| 2021-02-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 2,895 | 26.52 | 76,766 |
| 2021-02-18 | Glenn Gregory M (President, R&D) | Sale | 2,434 | 271.48 | 660,770 |
| 2021-02-16 | Glenn Gregory M (President, R&D) | Sale | 5,712 | 283.40 | 1,618,757 |
| 2021-02-16 | Glenn Gregory M (President, R&D) | Option Ex | 10,531 | 22.50 | 236,947 |
| 2021-02-09 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 194 | 324.50 | 62,953 |
| 2021-02-05 | Trizzino John (EVP, Chief Commercial Officer) | Sale | 3,022 | 291.50 | 880,903 |
| 2021-02-05 | Trizzino John (EVP, Chief Commercial Officer) | Option Ex | 3,406 | 21.38 | 72,803 |
| 2021-02-01 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 15,022 | 241.28 | 3,624,583 |
| 2021-02-01 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 15,022 | 26.71 | 401,237 |
| 2021-01-07 | Trizzino John (EVP, CMO and CBO) | Sale | 506 | 124.17 | 62,830 |
| 2021-01-05 | Trizzino John (EVP, CMO and CBO) | Sale | 17,407 | 112.71 | 1,961,995 |
| 2021-01-05 | Trizzino John (EVP, CMO and CBO) | Option Ex | 13,756 | 23.25 | 319,827 |
| 2021-01-01 | Young James F (Director) | Option Ex | 10,000 | .00 | 0 |
| 2020-12-31 | Young James F (Director) | Sale | 11,000 | 113.29 | 1,246,168 |
| 2020-12-31 | Young James F (Director) | Option Ex | 11,000 | 50.70 | 557,700 |
| 2020-12-31 | Douglas Richard (Director) | Option Ex | 1,000 | 50.00 | 50,000 |
| 2020-11-16 | Erck Stanley C (President and CEO) | Sale | 52,316 | 90.33 | 4,725,599 |
| 2020-11-16 | Erck Stanley C (President and CEO) | Option Ex | 52,317 | 32.70 | 1,710,765 |
| 2020-10-01 | Erck Stanley C (President and CEO) | Sale | 2 | 108.56 | 217 |
| 2020-09-30 | Trizzino John (EVP, CBO and CFO) | Sale | 2,250 | 111.32 | 250,463 |
| 2020-09-30 | Erck Stanley C (President and CEO) | Sale | 12,231 | 112.03 | 1,370,202 |
| 2020-09-29 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 18,029 | 107.79 | 1,943,291 |
| 2020-09-29 | Trizzino John (EVP, CBO and CFO) | Sale | 18,321 | 107.57 | 1,970,826 |
| 2020-09-29 | Erck Stanley C (President and CEO) | Sale | 4,112 | 107.78 | 443,195 |
| 2020-09-29 | Glenn Gregory M (President, R&D) | Sale | 19,949 | 107.77 | 2,149,823 |
| 2020-09-28 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 24,749 | 112.05 | 2,773,174 |
| 2020-09-28 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 24,750 | 5.95 | 147,262 |
| 2020-09-28 | Trizzino John (EVP, CBO and CFO) | Sale | 25,000 | 112.05 | 2,801,300 |
| 2020-09-28 | Trizzino John (EVP, CBO and CFO) | Option Ex | 29,600 | 5.95 | 176,120 |
| 2020-09-28 | Erck Stanley C (President and CEO) | Sale | 25,000 | 112.05 | 2,801,300 |
| 2020-09-28 | Erck Stanley C (President and CEO) | Option Ex | 50,000 | 5.95 | 297,500 |
| 2020-09-28 | Glenn Gregory M (President, R&D) | Sale | 25,000 | 112.05 | 2,801,300 |
| 2020-09-28 | Glenn Gregory M (President, R&D) | Option Ex | 25,000 | 5.95 | 148,750 |
| 2020-09-26 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 34,873 | .00 | 0 |
| 2020-09-26 | Trizzino John (EVP, CBO and CFO) | Option Ex | 35,438 | .00 | 0 |
| 2020-09-26 | Erck Stanley C (President and CEO) | Option Ex | 6,546 | .00 | 0 |
| 2020-09-26 | Glenn Gregory M (President, R&D) | Option Ex | 38,588 | .00 | 0 |
| 2020-08-18 | Herrmann John A Iii (EVP, Chief Legal Officer) | Sale | 46,242 | 144.35 | 6,675,263 |
| 2020-08-18 | Herrmann John A Iii (EVP, Chief Legal Officer) | Option Ex | 46,242 | 50.62 | 2,341,001 |
| 2020-08-18 | Trizzino John (EVP, CBO and CFO) | Sale | 42,788 | 148.82 | 6,367,924 |
| 2020-08-18 | Trizzino John (EVP, CBO and CFO) | Option Ex | 42,788 | 45.48 | 1,945,998 |
| 2020-08-18 | Glenn Gregory M (President, R&D) | Sale | 55,921 | 145.38 | 8,129,794 |
| 2020-08-18 | Glenn Gregory M (President, R&D) | Option Ex | 55,921 | 34.26 | 1,915,685 |
| 2020-08-18 | Evans Gary C (Director) | Sale | 10,500 | 150.44 | 1,579,620 |
| 2020-08-18 | Evans Gary C (Director) | Option Ex | 10,500 | 35.45 | 372,225 |
| 2020-08-18 | Mcmanus Michael A Jr (Director) | Sale | 8,000 | 146.00 | 1,168,000 |
| 2020-08-18 | Mcmanus Michael A Jr (Director) | Option Ex | 8,000 | 27.60 | 220,800 |
| 2020-06-18 | Glenn Gregory M (President, R&D) | Sale | 16,749 | 59.53 | 997,101 |
| 2020-06-18 | Glenn Gregory M (President, R&D) | Option Ex | 16,749 | 42.20 | 706,807 |
| 2020-06-03 | Young James F (Director) | Buy | 1,500 | 48.83 | 73,245 |
| 2020-05-18 | Herrmann John A Iii (SVP, General Counsel) | Sale | 12,961 | 49.44 | 640,791 |
| 2020-05-18 | Herrmann John A Iii (SVP, General Counsel) | Option Ex | 12,961 | 26.30 | 340,874 |
| 2020-03-08 | Herrmann John A Iii (SVP, General Counsel) | Option Ex | 449 | .00 | 0 |
| 2020-03-08 | Trizzino John (SVP, CBO and CFO) | Option Ex | 468 | .00 | 0 |
| 2020-03-08 | Erck Stanley C (President and CEO) | Option Ex | 6,072 | .00 | 0 |
| 2020-03-08 | Glenn Gregory M (President, R&D) | Option Ex | 760 | .00 | 0 |
| 2020-01-31 | Glenn Gregory M (President, R&D) | Buy | 1,250 | 3.86 | 4,825 |
| 2019-11-18 | Mcmanus Michael A Jr (Director) | Sale | 3,929 | 3.82 | 15,016 |
| 2019-09-17 | Herrmann John A Iii (SVP, General Counsel) | Sale | 3,643 | 7.07 | 25,756 |
| 2019-09-13 | Glenn Gregory M (President, R&D) | Sale | 9,620 | 6.18 | 59,480 |
| 2019-09-11 | Trizzino John (SVP, CBO and CFO) | Sale | 5,578 | 5.72 | 31,911 |
| 2019-09-08 | Herrmann John A Iii (SVP, General Counsel) | Option Ex | 4,933 | .00 | 0 |
| 2019-09-08 | Trizzino John (SVP, CBO and CFO) | Option Ex | 5,143 | .00 | 0 |
| 2019-09-08 | Glenn Gregory M (President, R&D) | Option Ex | 7,608 | .00 | 0 |
| 2019-05-13 | Glenn Gregory M (President, R&D) | Buy | 1,000 | 5.85 | 5,850 |
| 2019-03-27 | King Rachel K. (Director) | Buy | 86,000 | .53 | 45,580 |
| 2019-01-31 | Glenn Gregory M (President, R&D) | Buy | 13,168 | .88 | 11,587 |
| 2018-07-31 | Glenn Gregory M (President, R&D) | Buy | 13,007 | .88 | 11,446 |
| 2018-05-14 | Trizzino John (SVP, CBO and CFO) | Buy | 50,000 | 1.64 | 82,000 |
| 2018-05-14 | Erck Stanley C (President and CEO) | Buy | 100,000 | 1.65 | 164,600 |
| 2018-05-14 | Glenn Gregory M (President, R&D) | Buy | 20,000 | 1.64 | 32,759 |
| 2018-01-31 | Glenn Gregory M (President, R&D) | Buy | 12,784 | .88 | 11,249 |
| 2017-11-09 | Erck Stanley C (President and CEO) | Buy | 100,000 | 1.13 | 113,100 |
| 2017-11-09 | Glenn Gregory M (President, R&D) | Buy | 10,000 | 1.13 | 11,299 |
| 2017-08-31 | Young James F (Director) | Sale | 175,000 | 1.06 | 184,800 |
| 2017-07-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 2,057 | .89 | 1,830 |
| 2017-05-12 | Mcmanus Michael A Jr (Director) | Buy | 20,000 | .97 | 19,400 |
| 2017-05-11 | Erck Stanley C (President and CEO) | Buy | 50,000 | .84 | 42,000 |
| 2017-05-11 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 25,000 | .84 | 20,950 |
| 2017-05-11 | Mcmanus Michael A Jr (Director) | Buy | 10,000 | .84 | 8,400 |
| 2017-05-11 | Douglas Richard (Director) | Buy | 200,000 | .93 | 185,800 |
| 2017-03-14 | Young James F (Director) | Sale | 100,000 | 1.39 | 139,000 |
| 2017-01-31 | Herrmann John A Iii (SVP, General Counsel) | Buy | 4,960 | 1.12 | 5,555 |
| 2017-01-31 | Trizzino John (SVP, Commercial Operations) | Buy | 3,401 | 1.12 | 3,809 |
| 2017-01-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 1,633 | 1.12 | 1,828 |
| 2016-12-07 | Glenn Gregory M (President, R&D) | Buy | 1,000 | 1.45 | 1,446 |
| 2016-09-22 | Trizzino John (SVP, Commercial Operations) | Buy | 46,000 | 2.17 | 99,820 |
| 2016-09-21 | Glenn Gregory M (President, R&D) | Buy | 1,000 | 1.65 | 1,649 |
| 2016-09-21 | Mcmanus Michael A Jr (Director) | Buy | 30,000 | 1.61 | 48,300 |
| 2016-09-21 | Douglas Richard (Director) | Buy | 100,000 | 1.72 | 172,000 |
| 2016-09-20 | Boudreaux Gail (Director) | Buy | 100,000 | 1.45 | 144,900 |
| 2016-07-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 422 | 4.29 | 1,810 |
| 2016-05-24 | Evans Gary C (Director) | Sale | 16,134 | 5.42 | 87,494 |
| 2016-05-23 | Evans Gary C (Director) | Sale | 33,866 | 5.40 | 182,876 |
| 2016-03-31 | Erck Stanley C (President and CEO) | Sale | 226,769 | 5.18 | 1,175,570 |
| 2016-03-31 | Erck Stanley C (President and CEO) | Option Ex | 201,991 | 1.28 | 258,548 |
| 2016-03-30 | Erck Stanley C (President and CEO) | Sale | 198,009 | 5.19 | 1,028,062 |
| 2016-03-30 | Erck Stanley C (President and CEO) | Option Ex | 198,009 | 1.28 | 253,451 |
| 2016-01-31 | Herrmann John A Iii (SVP, General Counsel) | Buy | 2,072 | 4.38 | 9,075 |
| 2016-01-31 | Trizzino John (SVP, Commercial Operations) | Buy | 5,855 | 3.63 | 21,253 |
| 2016-01-31 | Erck Stanley C (CEO and President) | Buy | 2,072 | 4.38 | 9,075 |
| 2016-01-31 | Glenn Gregory M (SVP, Research and Development) | Buy | 2,369 | 4.38 | 10,376 |
| 2016-01-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 405 | 4.38 | 1,773 |
| 2015-12-16 | Herrmann John A Iii (SVP, General Counsel) | Sale | 27,945 | 8.64 | 241,416 |
| 2015-12-16 | Glenn Gregory M (SVP, Research and Development) | Sale | 61,886 | 8.57 | 530,672 |
| 2015-12-16 | Glenn Gregory M (SVP, Research and Development) | Option Ex | 61,886 | 1.83 | 113,251 |
| 2015-08-24 | Evans Gary C (Director) | Sale | 20,000 | 11.24 | 224,800 |
| 2015-08-20 | Phillips Barclay A (SVP, Chief Financial Officer) | Sale | 10,000 | 12.81 | 128,120 |
| 2015-08-19 | Phillips Barclay A (SVP, Chief Financial Officer) | Sale | 18,656 | 13.20 | 246,203 |
| 2015-08-19 | Mcmanus Michael A Jr (Director) | Option Ex | 50,000 | 2.17 | 108,250 |
| 2015-08-18 | Glenn Gregory M (SVP, Research and Development) | Sale | 15,000 | 13.52 | 202,740 |
| 2015-08-18 | Glenn Gregory M (SVP, Research and Development) | Option Ex | 15,000 | 2.11 | 31,649 |
| 2015-08-13 | Evans Gary C (Director) | Sale | 6,002 | 13.56 | 81,399 |
| 2015-08-13 | Evans Gary C (Director) | Option Ex | 45,000 | .92 | 41,400 |
| 2015-07-31 | Herrmann John A Iii (SVP, General Counsel) | Buy | 1,502 | 2.28 | 3,424 |
| 2015-07-31 | Trizzino John (SVP, Commercial Operations) | Buy | 5,098 | 3.63 | 18,505 |
| 2015-07-31 | Erck Stanley C (CEO and President) | Buy | 3,207 | 2.28 | 7,311 |
| 2015-07-31 | Glenn Gregory M (SVP, Research and Development) | Buy | 892 | 2.28 | 2,033 |
| 2015-07-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 764 | 2.28 | 1,741 |
| 2015-06-18 | Young James F (Director) | Sale | 50,000 | 9.47 | 473,600 |
| 2015-06-17 | Modi Rajiv I. (Director) | Sale | 152,768 | 9.01 | 1,376,439 |
| 2015-06-16 | Modi Rajiv I. (Director) | Sale | 280,285 | 9.01 | 2,525,367 |
| 2015-06-11 | Modi Rajiv I. (Director) | Sale | 11,185 | 9.00 | 100,665 |
| 2015-06-10 | Modi Rajiv I. (Director) | Sale | 297,375 | 9.01 | 2,679,348 |
| 2015-06-09 | Modi Rajiv I. (Director) | Sale | 47,531 | 8.93 | 424,451 |
| 2015-06-08 | Modi Rajiv I. (Director) | Sale | 206,175 | 8.93 | 1,841,142 |
| 2015-06-04 | Modi Rajiv I. (Director) | Sale | 65,589 | 8.92 | 585,053 |
| 2015-06-03 | Modi Rajiv I. (Director) | Sale | 355,000 | 8.92 | 3,166,600 |
| 2015-06-02 | Modi Rajiv I. (Director) | Sale | 84,092 | 8.90 | 748,418 |
| 2015-06-01 | Modi Rajiv I. (Director) | Sale | 1,500,000 | 8.80 | 13,200,000 |
| 2015-05-28 | Modi Rajiv I. (Director) | Sale | 2,000,000 | 8.70 | 17,400,000 |
| 2015-02-20 | Mcmanus Michael A Jr (Director) | Option Ex | 45,000 | 2.15 | 96,614 |
| 2015-01-31 | Herrmann John A Iii (SVP, General Counsel) | Buy | 9,869 | 2.28 | 22,501 |
| 2015-01-31 | Hahn Timothy Jon (SVP, Manufacturing) | Buy | 9,329 | 2.28 | 21,270 |
| 2015-01-31 | Trizzino John (SVP, Commercial Operations) | Buy | 6,611 | 3.63 | 23,997 |
| 2015-01-31 | Erck Stanley C (CEO and President) | Buy | 6,122 | 2.28 | 13,958 |
| 2015-01-31 | Wilson Russell P (SVP, Business Development) | Buy | 5,050 | 2.28 | 11,513 |
| 2015-01-31 | Glenn Gregory M (SVP, Research and Development) | Buy | 866 | 2.28 | 1,974 |
| 2015-01-31 | Phillips Barclay A (SVP, Chief Financial Officer) | Buy | 8,388 | 2.28 | 19,124 |
| 2014-06-17 | Mcmanus Michael A Jr (Director) | Option Ex | 45,000 | .92 | 41,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVAX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novavax Inc (symbol NVAX, CIK number 1000694) see the Securities and Exchange Commission (SEC) website.